Natco is a pharmaceutical company that specializes in the development, manufacture, and marketing of generic pharmaceutical products.
Natco was established in 1981.
The company is headquartered in Hyderabad, India.
Natco was initially focused on the development and manufacture of bulk drugs and active pharmaceutical ingredients (APIs).
In the 1990s, Natco expanded its operations to include finished dosage formulations (FDFs).
Natco became a publicly traded company on the Indian stock exchanges in 1995.
The company has a strong focus on research and development and has filed numerous Abbreviated New Drug Applications (ANDAs) with regulatory authorities worldwide.
Natco has received several approvals from the US Food and Drug Administration (FDA) for its generic products.
The company has also entered into licensing and supply agreements with international pharmaceutical companies.
Natco is committed to ensuring affordability and accessibility of quality healthcare through its generic medicines.
The company has a wide product portfolio that includes a range of therapeutic categories.
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company that develops and manufactures generic pharmaceutical products.
Cipla is a global pharmaceutical company that produces and distributes generic pharmaceutical products.
Sun Pharmaceutical Industries is an Indian multinational pharmaceutical company that specializes in generic and branded drugs.
Natco produces a wide range of generic medicines, including tablets, capsules, injectables, and oral suspensions, for various therapeutic areas.
Natco manufactures and supplies a variety of active pharmaceutical ingredients (APIs), which are the key components used in the production of generic medicines.
Natco offers a range of oncology products, including targeted therapies and chemotherapy drugs, for the treatment of various types of cancers.
Natco develops and markets affordable and effective medicines for the treatment of Hepatitis C, providing access to high-quality treatment options for patients.
Natco specializes in the development, manufacture, and marketing of generic pharmaceutical products.
Natco was established in 1981.
Natco is headquartered in Hyderabad, India.
Yes, Natco has received several approvals from the US Food and Drug Administration (FDA) for its generic products.
Natco has a wide product portfolio that covers various therapeutic categories, including oncology, hepatitis C, cardiovascular, respiratory, and more.